2,377
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Rapid and quantitative detection of urinary Cyfra21-1 using fluorescent nanosphere-based immunochromatographic test strip for diagnosis and prognostic monitoring of bladder cancer

, , , , , , & show all
Pages 4266-4272 | Received 20 Apr 2019, Accepted 16 Aug 2019, Published online: 15 Nov 2019

References

  • Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–E386.
  • Wong MCS, Fung FDH, Leung C, et al. The global epidemiology of bladder cancer: a joinpoint regression analysis of its incidence and mortality trends and projection. Sci Rep. 2018;8(1):1129.
  • Humphrey PA, Moch H, Cubilla AL, et al. The 2016 WHO classification of tumours of the urinary system and male genital organs-part B: prostate and bladder tumours. Eur Urol. 2016;70(1):106–119.
  • Lodewijk I, Duenas M, Rubio C, et al. Liquid biopsy biomarkers in bladder cancer: a current need for patient diagnosis and monitoring. Int J Mol Sci. 2018;19(9):2514.
  • Sylvester RJ, van der Meijden AP, Oosterlinck W, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol. 2006;49(3):466.
  • Babjuk M, Bohle A, Burger M, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol. 2017;71(3):447–461.
  • Agarwal PK, Black PC, Kamat AM. Considerations on the use of diagnostic markers in management of patients with bladder cancer. World J Urol. 2008;26(1):39–44.
  • D’Costa JJ, Goldsmith JC, Wilson JS, et al. A systematic review of the diagnostic and prognostic value of urinary protein biomarkers in urothelial bladder cancer. Bladder Cancer. 2016;2:301–317.
  • Chen LM, Chang M, Dai Y, et al. External validation of a multiplex urinary protein panel for the detection of bladder cancer in a multicenter cohort. Cancer Epidemiol Biomarkers Prev. 2014;23(9):1804–1812.
  • Zhang L, Liu D, Li L, et al. The important role of circulating Cyfra21-1 in metastasis diagnosis and prognostic value compared with carcinoembryonic antigen and neuron-specific enolase in lung cancer patients. BMC Cancer. 2017;17(1):96.
  • Zhao T, Jin Y, Mao G, et al. Cyfra21-1 is an early predictor of chemotherapeutic effectiveness in advanced nonsmall cell lung cancer: an observational study. Medicine (Baltimore). 2016;95(52):e5748.
  • Yuan C, Yang K, Tang H, et al. Diagnostic values of serum tumor markers Cyfra21-1, SCCAg, ferritin, CEA, CA19-9, and AFP in oral/oropharyngeal squamous cell carcinoma. Onco Targets Ther. 2016;9:3381–3386.
  • Yuan-Lan Huang JC, Yan W, Zang D, et al. Diagnostic accuracy of cytokeratin-19 fragment (Cyfra21–1) for bladder cancer: a systematic review and meta-analysis. Tumor Biol. 2015;36(5):3137–3145.
  • Leiblich A. Recent developments in the search for urinary biomarkers in bladder cancer. Curr Urol Rep. 2017;18(12):100.
  • Darwiche F, Parekh DJ, Gonzalgo ML. Biomarkers for non-muscle invasive bladder cancer: current tests and future promise. Indian J Urol. 2015;31(4):273–282.
  • Miyake M, Morizawa Y, Hori S, et al. Diagnostic and prognostic role of urinary collagens in primary human bladder cancer. Cancer Sci. 2017;108(11):2221–2228.
  • Chen J, Tao F, Zhang B, et al. Elevated squamous cell carcinoma antigen, cytokeratin 19 fragment, and carcinoembryonic antigen levels in diabetic nephropathy. Int J Endocrinol. 2017;2017:1.
  • Liu Yan-Hui L-L, Xiao-Hou WU, Xiao-Zhong CAI, et al. Research of the strip of immunocolloidal-gold with monoclonal antiCK20 antibody. Immunol J. 2007;23(1):101–106.
  • Wang HY, Hsieh CH, Wen CN, et al. Cancers screening in an asymptomatic population by using multiple tumour markers. PLoS One. 2016;11(6):e0158285.
  • Hou W, Wang S, Wang X, et al. Development of colloidal gold immunochromatographic strips for detection of Riemerella anatipestifer. PLoS One. 2015;10(3):e0122952.
  • Niu Y, Wang D, Cui L, et al. Monoclonal antibody-based colloid gold immunochromatographic strip for the rapid detection of Tomato zonate spot tospovirus. Virol J. 2018;15(1):15.
  • Chun-Yan Zhang J-X, Li W-J, Ou L-J, et al. [Preparation and fluorescence sensing properties of monodisperse bonded polystyrene-containing microspheres]. Chem J Chin Univ. 2019;40:153–159. Chinese
  • Cordina NM, Sayyadi N, Parker LM, et al. Reduced background autofluorescence for cell imaging using nanodiamonds and lanthanide chelates. Sci Rep. 2018;8(1):4521.
  • Liang RL, Deng QT, Chen ZH, et al. Europium (III) chelate microparticle-based lateral flow immunoassay strips for rapid and quantitative detection of antibody to hepatitis B core antigen. Sci Rep. 2017;7(1):14093.
  • Lai XH, Liang RL, Liu TC, et al. A fluorescence immunochromatographic assay using europium (III) chelate microparticles for rapid, quantitative and sensitive detection of creatine kinase MB. J Fluoresc. 2016;26(3):987–996.
  • Gahlaut N, Miller LW. Time-resolved microscopy for imaging lanthanide luminescence in living cells. Cytometry. 2010;77(12):1113–1125.
  • Yang M, Liang Y, Gui Q, et al. Multifunctional luminescent nanomaterials from NaLa(MoO4)2: Eu3+/Tb3+ with tunable decay lifetimes, emission colors, and enhanced cell viability. Sci Rep. 2015;5(1):11844.
  • Shen Y, Xu S, He D. A novel europium chelate coated nanosphere for time-resolved fluorescence immunoassay. PLoS One. 2015;10(6):e0129689.